Search - tctmd.com

Displaying 641 - 660 of 673

Sort: Relevancy | Date

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

Presentation GI2 2012

Dual Antiplatelet Therapy Post PCI: Challenging the Guidelines

Presenter: Fausto Feres

April 13, 2012

Presentation

Short- vs. Long-term Duration of Dual Antiplatelet Therapy (DAPT) After Coronary Stenting

Presenter: Marco Valgimigli

April 02, 2012

Presentation ACC 2012

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Presenter: Myeong-Ki Hong

March 25, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

News Daily News

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

L.A. McKeown

March 12, 2012

News Daily News

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

L.A. McKeown

March 12, 2012

Presentation

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Presenter: Hans-Christoph Diener

March 08, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Nuevo Análisis PLATO: Las dosis de Aspirina podrían Explicar los Resultados Discordantes de Norteamérica

Caitlin E. Cox

March 06, 2012

News Daily News

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Caitlin E. Cox

March 06, 2012

Presentation

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Presenter: S. Friedland

March 06, 2012

Presentation

Meta-Análisis of Ensayos Controlados Aleatorizaos sobre el Efecto del Cilostazol en la Re-estenosis y Resultados tras PCI

Presenter: S. Friedland

March 06, 2012

Presentation ISET 2012

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Presenter: Gunnar Tepe

January 17, 2012

News Daily News

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

L.A. McKeown

January 12, 2012

Presentation

Insuficiente Inhibición Plaquetaria asociada a Infartos Cerebrales Embólicos Silenciosos tras Angiografía

Presenter: B.J. Kim

January 12, 2012

Presentation

Insufficient Platelet Inhibition Related to Silent Embolic Cerebral Infarctions After Angiography

Presenter: B.J. Kim

January 12, 2012

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Daily News

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Yael L. Maxwell

September 26, 2011

Advertisement

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Dual Antiplatelet Therapy Post PCI: Challenging the Guidelines

Short- vs. Long-term Duration of Dual Antiplatelet Therapy (DAPT) After Coronary Stenting

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

Nuevo Análisis PLATO: Las dosis de Aspirina podrían Explicar los Resultados Discordantes de Norteamérica

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Meta-Análisis of Ensayos Controlados Aleatorizaos sobre el Efecto del Cilostazol en la Re-estenosis y Resultados tras PCI

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

Insuficiente Inhibición Plaquetaria asociada a Infartos Cerebrales Embólicos Silenciosos tras Angiografía

Insufficient Platelet Inhibition Related to Silent Embolic Cerebral Infarctions After Angiography

Six Months Sufficient for Dual Antiplatelet Therapy

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content